Cargando…
CVD and COVID-19: Emerging Roles of Cardiac Fibroblasts and Myofibroblasts
Cardiovascular disease (CVD) is the leading cause of death worldwide. Current data suggest that patients with cardiovascular diseases experience more serious complications with coronavirus disease-19 (COVID-19) than those without CVD. In addition, severe COVID-19 appears to cause acute cardiac injur...
Autores principales: | Katwa, Laxmansa C., Mendoza, Chelsea, Clements, Madison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031661/ https://www.ncbi.nlm.nih.gov/pubmed/35455995 http://dx.doi.org/10.3390/cells11081316 |
Ejemplares similares
-
The Eye of the Storm: Investigating the Long-Term Cardiovascular Effects of COVID-19 and Variants
por: Vishwakarma, Nandini, et al.
Publicado: (2023) -
Loss of Function in Dopamine D3 Receptor Attenuates Left Ventricular Cardiac Fibroblast Migration and Proliferation in vitro
por: Kisling, Andrew, et al.
Publicado: (2021) -
Cardiac Fibroblast to Myofibroblast Phenotype Conversion—An Unexploited Therapeutic Target
por: Czubryt, Michael P.
Publicado: (2019) -
Influence of Intrinsic Aerobic Exercise Capacity and Sex on Cardiac Injury Following Acute Myocardial Ischemia and Reperfusion
por: Alsahly, Musaad B., et al.
Publicado: (2021) -
Fibroblasts and myofibroblasts in wound healing
por: Darby, Ian A, et al.
Publicado: (2014)